Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-09-05 Sale | 2023-09-06 7:03 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 400 | $17.53 | $7,012 | 241,121 (Direct) | View |
2023-07-25 Sale | 2023-07-27 4:30 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 29,000 | $19.14 | $555,160 | 182,127 (Direct) | View |
2022-11-29 Sale | 2022-12-01 4:16 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 21,959 | $16.15 | $354,638 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-09-01 Exercise | 2023-09-06 7:08 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 4,707 | $0 | 60,917 (Direct) | View |
2023-09-01 Option Award | 2023-09-06 7:08 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 30,689 | $0 | 60,917 (Direct) | View |
2023-09-01 Tax Withholding | 2023-09-06 7:08 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 1,383 | $17.76 | 60,917 (Direct) | View |
2023-07-15 Option Award | 2023-09-06 7:08 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 581 | $12.35 | 60,917 (Direct) | View |
2023-09-01 Exercise | 2023-09-06 7:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 3,471 | $0 | 68,952 (Direct) | View |
2023-09-01 Option Award | 2023-09-06 7:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 45,113 | $0 | 68,952 (Direct) | View |
2023-09-01 Tax Withholding | 2023-09-06 7:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,896 | $17.76 | 68,952 (Direct) | View |
2023-07-15 Option Award | 2023-09-06 7:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 292 | $12.35 | 68,952 (Direct) | View |
2023-09-01 Exercise | 2023-09-06 7:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 16,561 | $0 | 470,185 (Direct) | View |
2023-09-01 Option Award | 2023-09-06 7:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 181,425 | $0 | 470,185 (Direct) | View |
2023-09-01 Tax Withholding | 2023-09-06 7:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 6,619 | $17.76 | 470,185 (Direct) | View |
2023-09-01 Exercise | 2023-09-06 7:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 4,556 | $0 | 76,486 (Direct) | View |
2023-09-01 Option Award | 2023-09-06 7:06 pm | N/A 2033-08-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 49,050 | $0 | 76,486 (Direct) | View |
2023-09-01 Tax Withholding | 2023-09-06 7:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 1,338 | $17.76 | 76,486 (Direct) | View |
2023-09-01 Exercise | 2023-09-06 7:04 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 4,691 | $0 | 185,121 (Direct) | View |
2023-09-01 Option Award | 2023-09-06 7:04 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 49,635 | $0 | 185,121 (Direct) | View |
2023-09-01 Tax Withholding | 2023-09-06 7:04 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 1,378 | $17.76 | 185,121 (Direct) | View |
2023-09-01 Exercise | 2023-09-06 7:03 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 4,623 | $0 | 241,121 (Direct) | View |
2023-09-01 Option Award | 2023-09-06 7:03 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 45,470 | $0 | 241,121 (Direct) | View |
2023-09-05 Exercise | 2023-09-06 7:03 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 400 | $1.86 | 241,121 (Direct) | View |
2023-09-01 Tax Withholding | 2023-09-06 7:03 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 1,241 | $17.76 | 241,121 (Direct) | View |
2023-07-25 Exercise | 2023-07-27 4:30 pm | N/A 2026-09-13 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 29,000 | $0 | 182,127 (Direct) | View |
2023-07-25 Exercise | 2023-07-27 4:30 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 29,000 | $1.86 | 182,127 (Direct) | View |
2023-06-29 Exercise | 2023-07-03 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Malley Thomas Director | 5,000 | $0 | 76,967 (Direct) | View |
2023-06-29 Exercise | 2023-07-03 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | McCain Tracey L Director | 5,000 | $0 | 5,000 (Direct) | View |
2023-06-29 Exercise | 2023-07-03 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director | 5,000 | $0 | 5,000 (Direct) | View |
2023-06-29 Exercise | 2023-07-03 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Popovits Kimberly J Director | 5,000 | $0 | 5,000 (Direct) | View |
2023-06-29 Exercise | 2023-07-03 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Cole G Bradley Director | 5,000 | $0 | 5,000 (Direct) | View |
2023-06-29 Exercise | 2023-07-03 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 5,000 | $0 | 5,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 5:37 pm | N/A 2033-06-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director | 113,690 | $0 | 2,853,967 (Indirect) | View |
2023-06-06 Option Award | 2023-06-08 4:23 pm | N/A 2033-06-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | Malley Thomas Director | 30,609 | $0 | 30,609 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 4:22 pm | N/A 2033-06-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | Popovits Kimberly J Director | 30,609 | $0 | 30,609 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 4:22 pm | N/A 2033-06-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director | 30,609 | $0 | 30,609 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 4:21 pm | N/A 2033-06-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 30,609 | $0 | 30,609 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 4:20 pm | N/A 2033-06-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | Cole G Bradley Director | 30,609 | $0 | 30,609 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 4:19 pm | N/A 2033-06-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | McCain Tracey L Director | 30,609 | $0 | 30,609 (Direct) | View |
2023-04-26 Exercise | 2023-04-28 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 990 | $0 | 14,395 (Direct) | View |
2023-04-26 Tax Withholding | 2023-04-28 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 291 | $11.15 | 14,395 (Direct) | View |
2023-04-10 Exercise | 2023-04-11 5:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 3,933 | $0 | 24,774 (Direct) | View |
2023-04-10 Tax Withholding | 2023-04-11 5:07 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 1,155 | $10.71 | 24,774 (Direct) | View |
2023-04-10 Exercise | 2023-04-11 5:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 2,477 | $0 | 19,984 (Direct) | View |
2023-04-10 Tax Withholding | 2023-04-11 5:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,353 | $10.71 | 19,984 (Direct) | View |
2023-04-10 Exercise | 2023-04-11 5:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 2,498 | $0 | 49,402 (Direct) | View |
2023-04-10 Tax Withholding | 2023-04-11 5:06 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 734 | $10.71 | 49,402 (Direct) | View |
2023-04-10 Exercise | 2023-04-11 5:05 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 9,992 | $0 | 265,680 (Direct) | View |
2023-04-10 Tax Withholding | 2023-04-11 5:05 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 2,933 | $10.71 | 265,680 (Direct) | View |
2023-04-10 Exercise | 2023-04-11 5:04 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 2,695 | $0 | 19,797 (Direct) | View |
2023-04-10 Tax Withholding | 2023-04-11 5:04 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 791 | $10.71 | 19,797 (Direct) | View |
2023-04-10 Exercise | 2023-04-11 5:03 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 2,727 | $0 | 128,245 (Direct) | View |
2023-04-10 Tax Withholding | 2023-04-11 5:03 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 801 | $10.71 | 128,245 (Direct) | View |
2023-04-01 Option Award | 2023-04-03 4:30 pm | N/A 2033-03-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 45,470 | $0 | 45,470 (Direct) | View |
2023-04-01 Option Award | 2023-04-03 4:30 pm | N/A 2033-03-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 30,689 | $0 | 30,689 (Direct) | View |
2023-04-01 Option Award | 2023-04-03 4:30 pm | N/A 2033-03-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 45,113 | $0 | 45,113 (Direct) | View |
2023-04-01 Option Award | 2023-04-03 4:30 pm | N/A 2033-03-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 49,050 | $0 | 49,050 (Direct) | View |
2023-04-01 Option Award | 2023-04-03 4:30 pm | N/A 2033-03-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 49,635 | $0 | 49,635 (Direct) | View |
2023-04-01 Option Award | 2023-04-03 4:30 pm | N/A 2033-03-31 | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 181,425 | $0 | 181,425 (Direct) | View |
2023-03-16 Exercise | 2023-03-20 5:20 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 5,396 | $0 | 43,596 (Direct) | View |
2023-03-16 Tax Withholding | 2023-03-20 5:20 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 507 | $11.46 | 43,596 (Direct) | View |
2023-03-20 Tax Withholding | 2023-03-20 5:20 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. CHIEF MEDICAL OFFICER | 1,078 | $11.12 | 43,596 (Direct) | View |
2023-03-16 Exercise | 2023-03-20 5:19 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 3,131 | $0 | 13,417 (Direct) | View |
2023-03-16 Tax Withholding | 2023-03-20 5:19 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 543 | $11.46 | 13,417 (Direct) | View |
2023-03-20 Tax Withholding | 2023-03-20 5:19 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,167 | $11.12 | 13,417 (Direct) | View |
2023-01-15 Option Award | 2023-03-20 5:19 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross CHIEF COMMERCIAL OFFICER | 1,844 | $9.56 | 13,417 (Direct) | View |
2023-03-16 Exercise | 2023-03-20 5:18 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 2,937 | $0 | 11,748 (Direct) | View |
2023-03-16 Tax Withholding | 2023-03-20 5:18 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 221 | $11.46 | 11,748 (Direct) | View |
2023-03-20 Tax Withholding | 2023-03-20 5:18 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 635 | $11.12 | 11,748 (Direct) | View |
2023-01-15 Option Award | 2023-03-20 5:18 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R CHIEF ACCOUNTING OFFICER | 704 | $9.56 | 11,748 (Direct) | View |
2023-03-16 Exercise | 2023-03-20 5:16 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 18,571 | $0 | 241,784 (Direct) | View |
2023-03-16 Tax Withholding | 2023-03-20 5:16 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 1,929 | $11.46 | 241,784 (Direct) | View |
2023-03-20 Tax Withholding | 2023-03-20 5:16 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K CHAIRMAN & CEO | 3,523 | $11.12 | 241,784 (Direct) | View |
2023-03-16 Exercise | 2023-03-20 5:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 4,946 | $0 | 122,069 (Direct) | View |
2023-03-16 Tax Withholding | 2023-03-20 5:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 577 | $11.46 | 122,069 (Direct) | View |
2023-03-20 Tax Withholding | 2023-03-20 5:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben CHIEF OPERATING OFFICER | 876 | $11.12 | 122,069 (Direct) | View |
2023-03-16 Exercise | 2023-03-20 5:14 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 3,030 | $0 | 11,555 (Direct) | View |
2023-03-16 Tax Withholding | 2023-03-20 5:14 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 256 | $11.46 | 11,555 (Direct) | View |
2023-03-20 Tax Withholding | 2023-03-20 5:14 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CHIEF FINANCIAL OFFICER | 634 | $11.12 | 11,555 (Direct) | View |
2022-11-29 Exercise | 2022-12-01 4:16 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 21,959 | $0 | 0 (Direct) | View |
2022-11-29 Exercise | 2022-12-01 4:16 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 21,959 | $1.59 | 0 (Direct) | View |